EC
EcoR1 Capital’s AnaptysBio ANAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175M | Hold |
7,880,094
| – | – | 10.36% | 4 |
|
|
2025
Q1 | $146M | Buy |
7,880,094
+6,646
| +0.1% | +$124K | 8.69% | 4 |
|
|
2024
Q4 | $104M | Buy |
7,873,448
+78,452
| +1% | +$1.04M | 3.94% | 8 |
|
|
2024
Q3 | $261M | Buy |
7,794,996
+273,972
| +4% | +$9.18M | 8.94% | 2 |
|
|
2024
Q2 | $188M | Hold |
7,521,024
| – | – | 5.77% | 4 |
|
|
2024
Q1 | $169M | Hold |
7,521,024
| – | – | 4.28% | 7 |
|
|
2023
Q4 | $161M | Hold |
7,521,024
| – | – | 4.18% | 7 |
|
|
2023
Q3 | $135M | Hold |
7,521,024
| – | – | 4.56% | 6 |
|
|
2023
Q2 | $153M | Hold |
7,521,024
| – | – | 3.75% | 7 |
|
|
2023
Q1 | $164M | Hold |
7,521,024
| – | – | 5.27% | 5 |
|
|
2022
Q4 | $233M | Hold |
7,521,024
| – | – | 7.09% | 4 |
|
|
2022
Q3 | $192M | Hold |
7,521,024
| – | – | 5.66% | 4 |
|
|
2022
Q2 | $153M | Hold |
7,521,024
| – | – | 5.27% | 6 |
|
|
2022
Q1 | $186M | Hold |
7,521,024
| – | – | 5.82% | 4 |
|
|
2021
Q4 | $261M | Hold |
7,521,024
| – | – | 8.33% | 2 |
|
|
2021
Q3 | $204M | Hold |
7,521,024
| – | – | 7.1% | 3 |
|
|
2021
Q2 | $195M | Buy |
7,521,024
+369,400
| +5% | +$9.58M | 7.29% | 3 |
|
|
2021
Q1 | $154M | Buy |
7,151,624
+3,928,300
| +122% | +$84.7M | 6.84% | 4 |
|
|
2020
Q4 | $69.3M | Hold |
3,223,324
| – | – | 3.73% | 9 |
|
|
2020
Q3 | $47.5M | Buy |
3,223,324
+148,310
| +5% | +$2.19M | 3.39% | 9 |
|
|
2020
Q2 | $68.7M | Buy |
3,075,014
+39,000
| +1% | +$871K | 5.07% | 8 |
|
|
2020
Q1 | $42.9M | Buy |
3,036,014
+1,069,914
| +54% | +$15.1M | 4.48% | 7 |
|
|
2019
Q4 | $31.9M | Buy |
+1,966,100
| New | +$31.9M | 2.88% | 13 |
|